The leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...

In an interview to ET, Sandeep Verma, country head, India, Bayer consumer health division in India, said the company will use its global ex...

Novartis has reached an agreement with U.S. regulators to hold a randomized trial of generic malaria drug hydroxychloroquine against COVID-...

Other companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing i...

As uncomfortable as it will be for the drugmakers, it may not result in much lasting damage.

The commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.

Elder Pharma was locked in upper circuit at Rs 311.05, up 5%. Novartis was trading 0.4% higher at Rs 467, while Sanofi India was down 0.5% ...

Sanofi, Novartis and GSK are in the race to buy out the domestic formulations business of debt-ridden Elder Pharmaceuticals.

Aventis Pharma, the Indian arm of Sanofi Aventis, is exiting its joint venture Chiron Behring Vaccines by selling its 49% to the other part...

British giant GlaxoSmithKline, France's Sanofi-Aventis, Swiss multinational Novartis, and US-based Johnson and Johnson have all made bids f...

The Bombay High Court has restrained Aventis Pharma from distributing anti-rabies vaccine Verorab, and allowed the arbitration application ...

Beware of Dogs! There is a shortage of anti-rabies vaccine in the country, thanks to a dispute between Novartis and Sanofi Aventis, which t...

Shares of multinational pharmaceutical companies on Wednesday extended gains on the BSE, cheering their parents’ move to hike stake in thes...

After the two leading pharma multinationals recently increased their stakes in their Indian units, people connected with the industry say t...

The Supreme Court today issued notice to Aventis Pharma Ltd on a petition filed by Novartis Vaccines & Diagnostics Inc seeking reference of...

Getting a patent in the US for improved versions of existing drugs is now proving to be more difficult.

Several of the world’s top drugmakers may weigh acquiring Bristol-Myers Squibb after it fired its chief executive, although suitors seem un...